Resotran (REH-zo-tran), a new GI motility agent for chronic constipation
Women will be trying Resotran (REH-zo-tran), a new GI motility agent for chronic constipation.
Think of it as a safer version of cisapride (Prepulsid) or tegaserod (Zelnorm). These were taken off the market due to cardiac toxicity.
Resotran (prucalopride) is more selective for 5-HT4 serotonin receptors in the GI tract that stimulate motility.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive